- Home
- BLDEW vs MMS Comparison
BLDEW vs MMS Comparison
Compare BLDEW & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- MMS
- Stock Information
- Founded
- BLDEW N/A
- MMS 1975
- Country
- BLDEW United States
- MMS United States
- Employees
- BLDEW 281
- MMS N/A
- Industry
- BLDEW Transportation Services
- MMS Business Services
- Sector
- BLDEW Consumer Discretionary
- MMS Consumer Discretionary
- Exchange
- BLDEW Nasdaq
- MMS Nasdaq
- Market Cap
- BLDEW N/A
- MMS N/A
- IPO Year
- BLDEW 2019
- MMS 1997
- Fundamental
- Price
- BLDEW $0.26
- MMS $79.20
- Analyst Decision
- BLDEW
- MMS Hold
- Analyst Count
- BLDEW 0
- MMS 1
- Target Price
- BLDEW N/A
- MMS N/A
- AVG Volume (30 Days)
- BLDEW N/A
- MMS 551.6K
- Earning Date
- BLDEW N/A
- MMS 11-20-2024
- Dividend Yield
- BLDEW N/A
- MMS 1.52%
- EPS Growth
- BLDEW N/A
- MMS 70.65
- EPS
- BLDEW N/A
- MMS 4.77
- Revenue
- BLDEW N/A
- MMS $5,250,280,000.00
- Revenue This Year
- BLDEW N/A
- MMS $9.08
- Revenue Next Year
- BLDEW N/A
- MMS $1.12
- P/E Ratio
- BLDEW N/A
- MMS $16.61
- Revenue Growth
- BLDEW N/A
- MMS 8.89
- 52 Week Low
- BLDEW N/A
- MMS $76.46
- 52 Week High
- BLDEW N/A
- MMS $93.97
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- MMS 25.27
- Support Level
- BLDEW N/A
- MMS $86.36
- Resistance Level
- BLDEW N/A
- MMS $92.63
- Average True Range (ATR)
- BLDEW 0.00
- MMS 2.50
- MACD
- BLDEW 0.00
- MMS -0.76
- Stochastic Oscillator
- BLDEW 0.00
- MMS 3.20
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.